Alan Baer Maderazo, VP, Qual, Reg, & Clin Affairs at GenMark Diagnostics, Inc. (GNMK), sold 552 shares at $12.72 ($7K) on 2020-11-25, disclosed to the SEC on 2020-11-25.
Scheduled sale ($7k) by VP, Qual, Reg, & Clin Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2021-02-24 | $3K | — | Filing → |
| GNMK | SELL | 2021-02-22 | $6K | — | Filing → |
| GNMK | SELL | 2021-01-29 | $189K | — | Filing → |